Background: Differences in microRNA (miRNA) profiles between patients with and without coronary heart disease (CHD)have not been fully determined. The purpose of the study was to evaluate in a multi-ethnic population in China the predictive value of miRNAs previously suggested to have a role in CHD. Subject and method: 932 participants were included, and plasma samples obtained. A quantitative reverse-transcription PCR(RT-qPCR) assay was conducted to confirm the concentration of plasma miRNAs. Circulating levels of miRNAs were quantified using the 2 -Δct method. The severity of coronary atherosclerosis was evaluated via Gensini Scores. Result: The circulating levels of the nine proposed miRNAs were not different among the five main ethnicities examined (all p > 0.05). The Spearman correlation analyses indicated that miR-221 and miR-130a were negatively associated with the severity of CHD as indicated by Gensini Scores (r = -0.106, p = 0.001;r = -0.073, p = 0.026). Results of the univariate analysis showed that lower circulating miR-221 (OR, 1.663; 95 % CI, 1.255-2.202, p = <0.001), miR-155 (OR, 1.520; 95 % CI, 1.132-2.042, p = 0.005), and miR-130a (OR, 1.943; 95 % CI, 1.410-2.678, p = <0.001) were potential risk factors for CHD. Moreover, miR-130a (OR, 2.405; 95 % CI, 1.691-3.421, p = <0.001) remained independently associated with the risk of CHD after adjusting for potential confounding factors. The analysis of the possible positive/ negative associations between miR-221, miR-155 and miR-130awere conducted. A positive association between miR-130a and miR-155 was found (SI = 1.60, SIM = 1.21 and AP = 0.22), and in these groups, the proportion of CHD attributable to the interaction between miR-130a and miR-155 was as high as 22 %. A negative interaction was found between miR-221 and miR-130a (SI = 0.68, SIM = 0.60 and AP = 0.27). Conclusion: Plasma levels of miR-221, miR130a and miR-155 decreased in patients with CHD, and miR-130a may be an independent predictor for CHD.
Introduction
Despite significant improvements in diagnosis and treatment in recent decades, cardiovascular diseases (CVD), particularly coronary heart disease (CHD), remain the leading cause of human morbidity and mortality in the world [1] . Data from the World Health Organization (WHO) shows that approximately 17.5 million people died from CVDs in 2012 (7.4 million caused by CHD), which accounts for 31 % of all global deaths [2] . In China, the age-standardized mortality of CVD in 2002 was 300 persons per 100,000 [3] . Early prevention of CHD is of clinical significance for the overall reduction of CVD mortality. Although significant advancement has been achieved for the early prediction of acute CVD, such as acute coronary syndrome, biomarkers for the detection chronic stable CHD remains a challenge in clinical practice.
CHD is caused by coronary atherosclerosis, an inflammatory disease due to the formation of plaque and subsequent obstruction of the coronary arteries. It has been suggested that during the process of plaque formation, the cellular components of the plaque may release miRNAs into the circulation. These have the potential to serve as new biomarkers for predicting CHD [4] [5] . miRNAs are endogenous, small non-coding RNAs which are ~22 nucleotides in length, and are involved in the post-transcriptional regulation of genes. Functional changes, including up-regulation and down-regulation of miRNAsare known to be involved in the pathogenesis of many diseases such as myocardial infarction [6] [7] [8] [9] , coronary artery calcification (CAC) [10] , arrhythmia [11] , cardiomyocyte hypertrophy [12] [13] , heart failure [14] , renal ischemia-reperfusion injury [15] , non-alcoholic fatty liver disease [16] , tuberculosis [17] , pancreatic ductal adenocarcinoma [18] , and diabetes mellitus [19] . miRNAs are reported to not only exist within the cell but also reside stably in the extracellular compartments such as the circulation, which enables relatively simple detection of miRNAs as disease biomarkers. Another interesting characteristic of diseasespecific miRNAs is that they may be ethnicity specific [20] . Moreover, accumulating evidence indicates that some miRNAs may be specific for patients with CHD [21] . However, the potential role of these miRNAs in multi-ethnic CHD patients has rarely been reported. In this study, we aimed to evaluate the predictive value of previously suggested miRNAs for CHD in a multi-ethnic population in China.
Subject and Methods

Study subjects
From March 1, 2010 to April 31, 2015, 932 consecutive adult subjects (681 males and 251 females) aged 32-84 years, who underwent coronary angiography for suspected or known coronary atherosclerosis at the Friendship Hospital of Ili Kazakh Autonomous Prefecture in China, were selected in this study. Among the 932 subjects, 587 subjects were of Han ethnicity, 146 were of Uygur ethnicity, 91 were of Kazakh ethnicity, 67 were of Hui ethnicity, and 41 were of other ethnicities (5 were of Mongol ethnicity, 26 were of Siwe ethnicity, 2 were of Kyrgyz ethnicity, 2 were of Uzbeks ethnicity, 2 were of Manju ethnicity, 2 were of Daur ethnicity, and 2 were of Russian ethnicity).Subjects with spastic angina pectoris, infectious processes within 2 weeks, heart failure, adrenal dysfunction, and thyroid dysfunction were excluded. The study was performed in accordance with approved guidelines, and all experimental protocols were approved by the ethics committee of the First Affiliated Hospital of Nanjing Medical University and the Friendship Hospital of Ili Kazakh Autonomous Prefecture in China. All subjects provided written informed consent.
Coronary Angiography
Coronary arteries were cannulated using either the Judkins technique [22] or through a radial artery approach with 6F catheters and recorded at a rate of 30 frames/s. Significant CHD was defined as at least one major epicardial vessel with > 50 % stenosis; control subjects were defined as all of the major epicardial vessels with < 50 % stenosis [23] . The severity of the coronary atherosclerosis was based on the Gensini scoring system [24] [25] [26] [27] .
Laboratory measurements
Four millilitres of venous blood was drawn after 12 hours of fasting to perform biochemical assays on the second day of hospitalization; total cholesterol (TCH, mmol/L), triglyceride (TG, mmol/L), fasting blood glucose (FBG, mmol/L), creatinephosphokinase-myoglobin isoenzyme(CK-MB, U/L), fasting highdensity lipoprotein cholesterol (HDL-C, mmol/L), fasting low-density lipoprotein cholesterol (LDL-C, mmol/L), apolipoprotein A (Apo-A, g/L) and apolipoprotein B (Apo-B, g/L) were determined by enzymatic procedures on an automated autoanalyzer (AU 2700 Olympus, 1st Chemical Ltd, Japan). Excellent intraassay and inter-assay CVs of < 5 % were obtained with our assay method.
Selection of miRNAs
Based on previous studies [28] , nine CHD-related miRNAs were proposed as candidates in the study. This includedmiR-122, miR-133b [29] , miR-214 [30] , miR-21, miR-106a [31] , miR-130a, miR-155, miR-221 [32] , and miR-125b [33] [34] [35] [36] .
Plasma preparation and RNA isolation All samples (5 ml) were collected in EDTA plasma tubes on the morning following arrival. Samples were processed within 4 hours and stored at 4 °C. Plasma was collected after centrifugation (15 min at 1000 ×g) and was stored at -80 °C until further analysis.
For the RT-qPCR assay of plasma, total RNA was extracted using the one-step phenol/chloroform purification protocol, as previously reported [37] .
Quantification of miRNAs by RT-qPCR analysis
For miRNA profiling, the RT-qPCR assay was performed using a TaqMan PCR kit according to the manufacturer's instructions (Applied Biosystems, Foster City, USA); a minor modification was made according to the State Key Laboratory of Pharmaceutical Biotechnology (School of Life Sciences, Nanjing University), reported in 2010 [38] . Due to the superior performance of a combination of let-7d, let-7g and let-7i, this combination was chosen as a reference for the normalization of plasma miRNAs rather than the commonly used reference genes U6, RNU44, RNU48 and miR-16 [39] . The resulting threshold cycle (CT) values were determined according to the default threshold settings when the reactions were complete. The relative amount of each miRNA was calculated based on the internal control (i.e., the combination of let-7d, let-7g and let-7i, analysed using the 2 -Δct method, which is a widely used method for presenting relative gene expression by comparative CT). The calculation formula was as following: 2exp -(mean CT target miRNAmean CT internal control) [40] [41] for CT < 40 and 2 -40 in the case Ct ≥40 (considered as undetermined) [42] . The rate of undetermined miRNAs (CT >40) was as following: 47.1 % for miR-125b, 26.7 % for miR-122, 49.1 % for miR-214, 38.5 % for miR-133b, 10.8 % for miR-221, 8.3 % for miR-21, 8.2 % for miR-155, 8.9 % for miR-106a, and 8.0 % for miR-130a.
Gene Ontology and Pathway analysis
Gene Ontology (GO) functional classification was performed byBlast2GO software (http://www. blast2go.de), and contigs were divided into biological processes, cellular components and molecular functions according to GO terms.GO analysis was used to analyze the main function of differently expressed genes according to GO, which is the key functional classification of NCBI. This classification system organizes genes into hierarchical categories and identifies the gene regulatory network based on biological process, cellular components and molecular functions. A two-tailed Fisher's exact test and Χ 2 test were used to classify the GO category, and the FDR was calculated to correct the P value. A smaller FDR indicated a smaller error in judging the P value.Pathway analysis was used to determine significant pathways based on differential gene expression according to the KEGG. Fisher's exact test was used to select the significant pathway, and the threshold of significance was defined by the P value and FDR.
Statistical analysis
Data were statistically analysed using Statistics Package for Social Sciences (ver. 16.0; SPSS Incorporated, Chicago, IL, USA). Subjects were classified into five groups according to ethnicity, two groups according to CHD status and four groups according to the quartile of the Gensini score. Data for age, TG, TCH, HDL-C, LDL-C, FBG, CK-MB, Apo-A, Apo-B, Gensini scores, miR-122, miR-133b, miR-214, miR-21, miR-106a, miR-130a, miR-155, miR-221, and miR-125b were skewed distributed parameters and were expressed as median and quartile ranges, with comparisons performed using the Mann-Whitney U test and Kruskal-Wallis H test. The categorical variable of gender was compared between or among the groups of patients using a chi-squared analysis. The Spearman two-way test was used to assess the relationship between Gensini scores with miRNAs and classical risk factors. The receiver operating characteristic (ROC) curve was performed, and the area under the ROC curve (AUC) was calculated to evaluate the specificity and sensitivity of CHD prediction for each miRNA [43] . ORs regarding the presence of obstructive CHD were determined via either a univariate or a multivariate logistic regression analysis and are presented with 95 % CIs. Differences were considered to be significant if the null hypothesis could be rejected with > 95 % confidence. All P-values were two-tailed.To further explore the synergistic effect of miRNA on the risk of CHD, a 4×2 table approach was conducted to calculate odds ratios (ORs), 95 % confidence intervals (CIs) and two-tailed P-values, and multiple indexes (SI, SIM, RERI, and AP) were used to evaluate the synergistic effect between miRNAs [44, 45] .
Results
Baseline characteristics of subjects grouped according to ethnicity
A total of 932 subjects (681 males and 251 females) with a median age of 60-years were selected in the study. The baseline characteristics of the subjects grouped according to ethnicity are presented in Table 1 
Demographic, clinical and biochemical characteristics of subjects according to Gensini Score
Gensini Score of the subjects in the present study ranged from 0 to 240.00, with a median of 16.00 (quartile range, 3.00-45.00). Table 2 shows the demographic, clinical and Table 1 . Baseline characteristics of the subjects grouped according to ethnicity. Data are summarized by 50th (25th/75th) percentiles for continuous variables and N 1 /N 2 for binary variables. CK-MB, MB isoenzyme of creatine kinase; TCH, total cholesterol; TG, triglyceride; HDL-C, fasting high-density lipoprotein cholesterol; LDL-C, fasting low-density lipoprotein cholesterol; Apo-A, apolipoprotein A; Apo-B, apolipoprotein A; FBG, fasting blood glucose. The value of each miRNA means the relative amount calculated by 2 -Δct method 
Correlations of Gensini Score with clinical characteristics and circulating miRNAs
As shown in Table 3 
Spearman correlations of miRNAs with clinical characteristics and the other miRNAs
As shown in Table 4 and 5, using nonparametric Spearman correlation tests for all collected variables, we found that in all subjects, miR-221 was associated with LDL-C (r = 
Predictors of CHD prevalence: results of ROC analyses
To further explore the applicability of circulating miRNAs and classical risk factors as potential diagnostic biomarkers of CHD, subsequent ROC analyses were performed, and the Table 6 . Receiver operating characteristic curve analyses for the predicting of CHD prevalence. CI, confidence interval; AUC, area under the receiver operating characteristic curve; CHD, coronary heart disease; CK-MB, MB isoenzyme of creatine kinase; TCH, total cholesterol; TG, triglyceride; HDL-C, fasting high-density lipoprotein cholesterol; LDL-C, fasting low-density lipoprotein cholesterol; Apo-A, apolipoprotein A; Apo-B, apolipoprotein A; FBG, fasting blood glucose. The value of each miRNA means the relative amount calculated by 2 -Δct method. AUC, the closer it is to 0.5, the less predictive it is results are shown in Table 6 . The AUC for the predicting of CHD prevalence was 0.587 for age (Fig. 1 ), miR-155 had an AUC of0.504 (95 % CI: 0.501-0.579, p = 0.049) (Fig. 2 ) and miR-130a had an AUC of 0.566 (95 % CI: 0.525~0.606, p = 0.001) (Fig. 3) . The optimal cut-off value, the sensitivity, the specificity and Youden index of age, CK-MB, HDL-C, Apo-A, FBG, miR-221, miR-155 and miR-130a are shown in Table 7 .
Predictors of CHD prevalence: results of logistic regression analyses
We performed a miRNAs score analysis to evaluate the associations between the combination of the plasma miRNAs and CHD. Briefly, the miRNAs score of each miRNA (miR-221, miR-155 and miR-130a), was set to 1 if its concentration was lower than the optimal cutoff value for the corresponding miRNA. Otherwise the score was set to 0. Thus, the miRNAs score was the sum of the score of miR-221, miR-155 and miR-130a. The characteristics of the study population categorized by the miRNAs score were shown in Table 8 . The results of the univariate logistic regression analysis for the predictors of CHD prevalence are shown in Table 9 . Older age, male, higher CK-MB, lower HDL-C, and lower Apo-A level were potential predictors of CHD. Moreover, lower circulating miR-221(OR, 1.663; 95 % CI, 1.255-2.202, p = <0.001), miR-155(OR, 1.520; 95 % CI, 1.132-2.042, p = 0.005), and miR-130a (OR, 1.943; 95 % CI, 1.410-2.678, p = <0.001) were significantly associated with CHD in the univariable analysis.
It was assumed that subjects with a miRNA score of 0 have a background risk of CHD (OR is assumed to be 1); the results of the univariate logistic regression analysis indicated that the relative risk of CHD among the subjects with miRNAs scores of 1 and 2 and were Table 8 . Characteristics of the study population categorized by the miRNAs score: results of K independent sample test. CK-MB, MB isoenzyme of creatine kinase; TCH, total cholesterol; TG, triglyceride; HDL-C, fasting high-density lipoprotein cholesterol; LDL-C, fasting low-density lipoprotein cholesterol; Apo-A, apolipoprotein A; Apo-B, apolipoprotein A; FBG, fasting blood glucose A multivariate logistic regression analysis (Forward: Conditional method) was used to identify the risk factors for CHD among the entire population. In the multivariate model involving the entire population, we included the following variables: age, gender, TCH, TG, FBG, HDL-C, LDL-C, CK-MB, Apo-A, Apo-B, miR-122, miR-133b, miR-214, miR-21, miR-106a, miR-130a, miR-155, miR-221, and miR-125b. The results are reported as adjusted ORs and 95 % confidence intervals in Table 10 . Older age, male, higher CK-MB, lower HDL-C, higher FBG, and lower miR-130a (OR, 2.405; 95 % CI, 1.691-3.421, p = <0.001) remained independently associated with the risk of CHD.
Interaction between miR-221, miR-155 and miR-130a
The analysis of the possible positive/negative associations between miR-221, miR-155 and miR-130a are expressed in Table 11 . According to the results of the ROC analysis, subjects with a miR-221, miR-155 and miR-130a concentration below 0.114, 100.427, and 6.521 were consideredto have an elevated risk of CHD, respectively. Regarding the baseline risk for subjects unexposed to risk expression of miR-221, miR-155 or miR-130a (reference category, 1.0), the OR estimating the joint effect of miR-221 with miR-155, miR-221 with miR-130a, and miR-155 with miR-130a was significantly higher than the ORs estimating the effects of each factor in the absence of the other respectively. A positive association between miR-130a and miR-155 was found (SI = 1.60, SIM = 1.21 and AP = 0.22), and in these groups, the proportion of CHD attributable to the interaction between miR-130a and miR-155 was as high as 22 %. A negative interaction was found between miR-221 and miR-130a (SI = 0.68, SIM = 0.60 and AP = 0.27).
Functional annotation of the target genes for miR-221
To further identify the putative function of the predicted target genes for miR-221, GO analysis was performed. Eighteen different biological processes, four cellular components and six different molecular functions were predicted (Fig. 4) . The most significantly enriched GO terms were involved in three main categories: protein transport, protein localization, and establishment of protein localization. These results suggested that regulation of protein transport and localization played a vital role in the process of the CHD for miR-221. In addition, KEGG analysis was further conducted to elucidate the biological pathways of the miR-221 target genes (Fig. 5) . The categories of neurotrophin signaling pathway, T cell receptor signaling pathway, and ErbB signaling pathway were the most enriched pathways, which were all in the group of "signaling pathways". This suggested that miR-221 regulation of signaling pathway genes played crucial roles in the development of CHD.
Functional annotation of the target genes for miR-155
The GO/pathway analysis results for miR-155are presented in Fig. 6 and Fig. 7 . The most significantly enriched GO terms for miR-155 involved three main categories, including enzyme binding, transmembrane receptor protein serine/threonine kinase activity, and transforming growth factor beta receptor activity. Moreover, KEGG analysis suggests that the categories of pathways in cancer, pancreatic cancer, and colorectal cancer were the most enriched pathways, which were all in the group of cancer pathways. Fig. 8 indicates that the most significantly enriched GO terms for miR-130a were the three main categories of regulation of transcription, regulation of cell cycle, and regulation of protein catabolic process. These results suggest that regulation of transcription played a vital role in the process of the CHD for miR-221. In addition, KEGG analysis presented in Fig. 9 suggest that the categories of viral myocarditis, endocytosis, and neuroactive ligand− receptor interaction were the most enriched pathways. 
Functional annotation of the target genes for miR-130a
Discussion
In this study, we evaluated the predictive role of circulating miRNAs for CHD in a multiethnic population in China. We found that serum miR-155, miR-221 and miR-130a were significantly reduced in patients with CHD as compared with controls. More importantly, lower circulating miR-155, miR-221 and miR-130a were all significant predictors of CHD prevalence in this population. More importantly, miR-130a remained the independent predictor for CHD prevalence after adjustment for conventional confounding factors. To the best of our knowledge, ours is the first study that evaluates circulating miRNAs in a multiethnic population of documented CHD patients and control subjects. These results suggest that miRNAs, particularly miR-130a, may be novel biomarkers for CHD risk in this multiethnic population. Cohort studies are needed to confirm our results, and mechanism analyses are needed to determine the role of miRNAs in the pathogenesis of CHD.
miRNAs are endogenous, non-coding, and small (18-22 nucleotides) RNA molecules. miRNAs are recruited to the RNA-induced silencing complex (RISC) and regulate the output of protein-coding genes through diverse mechanisms [46] . The interaction of miRNAs with the 3′untranslated region (3′UTR) of protein-coding genes is considered as the main mechanism of action, which usually leads to a decrease in protein output either by mRNA degradation or by translational repression [47] . Recent studies have shown that miRNAs are key regulators of gene expression. The expression levels of miRNAs have been shown to be associated with CVD [48] , cancer [49] , and other diseases [50] . In addition, miRNAs have been used as potential biomarkers for both non-communicable and communicable diseases [51, 52] . However, to date, miRNA expression differences have not been reported in a multi-ethnic population. In the present study, we systematically explored nine CHD-related miRNAs in plasma from 932 CHD patients and non-CHD controls, with the results suggesting that the expression level of the miRNAs was not different among the various ethnic groups.
Results from our study indicate that miRNAs, particularly miR-155, miR-221 and miR130a may be novel markers of CHD. As a specific miRNA identified in human umbilical vein endothelial cells (HUVECs), miR-221 participates in the regulation of angiogenesis Fig. 8 . GO analysis of the target genes for miR-130a. Fig. 9 . KEGG pathways of the target genes for miR-130a. [53] . Previous findings demonstrate that miR-221 inhibits the proliferation of endothelial progenitor cells (EPC) via interactions with the MEK/ERK pathway, thereby indicating a potential role of miR-221 for maintaining the integrity of the endothelium [54] . Interestingly, treatment with atorvastatin increased EPC numbers and decreased miR-221/222 levels in patients with CHD [55] . As for miR-155, it has been demonstrated thatmiR-155 exerts an antiangiogenic but proarteriogenic function in the regulation of neovascularization via the suppression of divergent cell-specific target genes in mice [56] . In fact, a previous study has concluded that circulating miR-155 is lower in CHD patients, and inversely associated with the extent of coronary stenosis as indicated by the Gensini Scores [57] . Also, miR-130a has also been implicated in the angiogenic process [58, 59] , demonstrating that the overexpression of miR-130a may contribute importantly to gap junction remodeling and to the pathogenesis of atrial and ventricular arrhythmias [60] . Moreover, miR-130a has been implicated in the process of cardiac development, perhaps via regulation of FOG-2 (also known as zfpm2) [61] . Results from our study further confirmed the potential association between the expression of the above three miRNAs and CHD. Moreover, expression of these miRNAs also correlated with the severity of coronary lesions as indicated by Gensini Scores. These results should be verified in future cohort studies, and the exact mechanisms underlying the role of the above miRNAs in the pathogenesis of CHD deserves further investigation.
To comprehensively investigate miR-221, miR-155, miR-130aand their targets and provide some information for further understanding the miRNA-mediated regulation network in the development of CHD, GO/pathwayenrichmentanalysis was conducted in this study. Our analysis showed that miR-221, miR-155, and miR-130a contribute to various biological processes, including the regulation of protein transport and localization, cancer related pathways, endocytosis, and neuroactive ligand−receptor interactions. Taken together, these results represented partial information on the biological function of miRNA in the occurrence and development of CHD. However, the exact mechanisms underlying the association of miRNA and CHD require further study.
Our study has limitations which should be considered when interpreting the results. Firstly, our study is cross-sectional in design. Although we adjustedfor conventional risk factors of CHD, the potential association between the aforementioned miRNAs and CHD prevalence may be confounded by residue factors. Moreover, our study only provides evidence for the potential association between the miRNAs and CHD; whether changes in the miRNAs identified are causative to the pathogenesis of CHD requires further evaluation. Finally, the results may be different according to the different populations included. Therefore, further studies are needed to confirm our results.
In summary, expression levels of miR-221, miR-155, and miR-130a were decreased in CHD patients compared with controls and may be predictive of CHD risk in this population. Our findings suggested that miR-221, miR-155, and miR-130a might play an important role in the development of CHD, serving as a potential biomarker for predicting CHD. Cohort studies are needed to confirm our results, and mechanism analyses are needed to determine the role of miRNAs in the pathogenesis of CHD.
